During the past decade, Ospedale Civile di Montichiari; Centro Sclerosi Multipla conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile di Montichiari; Centro Sclerosi Multipla" are "Relapsing Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Primary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Ospedale Civile di Montichiari; Centro Sclerosi Multipla" in a lesser frequency.

Most popular intervention types in "Ospedale Civile di Montichiari; Centro Sclerosi Multipla" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Fenebrutinib" (2 trials), "Desloratadine given orally" (1 trials), "Dexamethasone given orally" (1 trials) and "Diphenhydramine IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile di Montichiari; Centro Sclerosi Multipla" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Civile di Montichiari; Centro Sclerosi Multipla". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ospedale Civile di Montichiari; Centro Sclerosi Multipla, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile di Montichiari; Centro Sclerosi Multipla, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".